Note: Ingredients listed on restricted chemical lists
EC/CAS
200-098-7/51-43-4
Name of the chemical
Epinephrine (INN)
Concentration
<= 100 %
General Information
Version
6.7
Product name
Noradrenaline impurity D
CAS No.
51-43-4
REACH No
is
Emergency telephone
+49 (0)696 43508409
Icons in SDS
Company Information
company name
Sigma-Aldrich Chemie GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
technischerservice@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H301+H331, H310, H331
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 3) H301: Toxic if swallowed. Acute toxicity, (Category 3) H331: Toxic if inhaled. Acute toxicity, (Category 2) H310: Fatal in contact with skin.
2.2 Label elements
Labelling
Signal word
Danger
Hazard statements
H301 + H331 Toxic if swallowed or if inhaled. H310 Fatal in contact with skin.
Precautionary statements
P261 Avoid breathing dust. P262 Do not get in eyes, on skin, or on clothing. P280 Wear protective gloves/ protective clothing. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P302 + P352 + P310 IF ON SKIN: Wash with plenty of water. Immediately call a POISON CENTER/ doctor. P304 + P340 + P311 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
